| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NRCNational Research Corporation | 482.6M | 21.30 | 20.48 | -3.72% | 11.76% | 114.31% | 3.97% | 2.06 |
| WORXSCWorx Corp. | 2.91M | 0.18 | -0.24 | -21.43% | -139.71% | -64.87% | 0.01 | |
| DHDefinitive Healthcare Corp. | 251.03M | 2.43 | -0.69 | 0.31% | -77.88% | -48.42% | 18.27% | 0.42 |
| HCATHealth Catalyst, Inc. | 165.51M | 2.34 | -2.03 | 3.6% | -34.05% | -32.42% | 1.10 | |
| ZCMDZhongchao Inc. | 12.21M | 0.47 | -3.95 | -18.37% | -26.94% | -34.62% | 0.00 | |
| EVHEvolent Health, Inc. | 439.71M | 3.94 | -4.86 | 30.09% | -6.24% | -15.22% | 0.71 | |
| FORAForian Inc. | 66.18M | 2.13 | -17.75 | -1.6% | -3.03% | -2.74% | 0.43% | 0.22 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 591.44K | 4.22M | 150.09K | 5.55M | 5.21M | 4.63M | 4.04M | 3.8M | 2.99M |
| Revenue Growth % | - | 6.13% | -0.96% | 35.97% | -0.06% | -0.11% | -0.13% | -0.06% | -0.21% |
| Cost of Goods Sold | 384.42K | 2.69M | 2.91M | 4.38M | 3.52M | 2.78M | 2.62M | 2.54M | 2.24M |
| COGS % of Revenue | 0.65% | 0.64% | 19.42% | 0.79% | 0.67% | 0.6% | 0.65% | 0.67% | 0.75% |
| Gross Profit | 207.01K | 1.53M | -2.76M | 1.17M | 1.7M | 1.85M | 1.41M | 1.27M | 745.99K |
| Gross Margin % | 0.35% | 0.36% | -18.42% | 0.21% | 0.33% | 0.4% | 0.35% | 0.33% | 0.25% |
| Gross Profit Growth % | - | 6.37% | -2.81% | 1.42% | 0.46% | 0.09% | -0.24% | -0.1% | -0.41% |
| Operating Expenses | 5.12M | 9.22M | 3.5M | 13.06M | 7.74M | 5.66M | 3.54M | 2.72M | 2.01M |
| OpEx % of Revenue | 8.65% | 2.19% | 23.34% | 2.35% | 1.49% | 1.22% | 0.88% | 0.71% | 0.67% |
| Selling, General & Admin | 5.12M | 9.22M | 3.5M | 13.06M | 7.74M | 5.66M | 3.54M | 2.72M | 756.12K |
| SG&A % of Revenue | 8.65% | 2.19% | 23.34% | 2.35% | 1.49% | 1.22% | 0.88% | 0.71% | 0.25% |
| Research & Development | 1.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 1.89% | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -3.35K | -16.86K | 231.04K | 0 | 0 | 0 | 0 | 0 | 1.25M |
| Operating Income | -4.91M | -11.27M | -3.58M | -11.9M | -6.05M | -3.81M | -2.12M | -1.45M | -1.26M |
| Operating Margin % | -8.3% | -2.67% | -23.87% | -2.14% | -1.16% | -0.82% | -0.53% | -0.38% | -0.42% |
| Operating Income Growth % | - | -1.3% | 0.68% | -2.32% | 0.49% | 0.37% | 0.44% | 0.32% | 0.13% |
| EBITDA | -4.51M | -11.2M | -3.54M | -11.86M | -5.81M | -3.74M | -1.84M | -3.97M | 0 |
| EBITDA Margin % | -7.63% | -2.65% | -23.6% | -2.14% | -1.11% | -0.81% | -0.46% | -1.04% | - |
| EBITDA Growth % | - | -1.48% | 0.68% | -2.35% | 0.51% | 0.36% | 0.51% | -1.16% | 1% |
| D&A (Non-Cash Add-back) | 397.44K | 76.18K | 40.83K | 41.23K | 234.26K | 76.16K | 0 | 0 | 1.26M |
| EBIT | -4.92M | -3.17M | -3.53M | -11.29M | -6.05M | -3.81M | -1.84M | -3.97M | -1.03M |
| Net Interest Income | 0 | 0 | -258.8K | 14.05K | 0 | 0 | -3.15K | -6.45K | -104.2K |
| Interest Income | 0 | 0 | 0 | 37.77K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 258.8K | 23.72K | 0 | 0 | 3.15K | 6.45K | 104.2K |
| Other Income/Expense | -3.35K | -2.87M | -204.2K | 584.99K | -1.36M | 0 | 276.04K | -2.53M | 123.2K |
| Pretax Income | -4.92M | -11.29M | -3.79M | -11.31M | -7.4M | -3.81M | -1.85M | -3.98M | -1.14M |
| Pretax Margin % | -8.31% | -2.68% | -25.24% | -2.04% | -1.42% | -0.82% | -0.46% | -1.05% | -0.38% |
| Income Tax | -755.65K | 688.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.85% | 1.06% | 3.85% | 1.01% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -4.16M | -11.98M | -14.59M | -11.48M | -7.4M | -3.81M | -1.85M | -3.98M | -1.14M |
| Net Margin % | -7.03% | -2.84% | -97.22% | -2.07% | -1.42% | -0.82% | -0.46% | -1.05% | -0.38% |
| Net Income Growth % | - | -1.88% | -0.22% | 0.21% | 0.36% | 0.48% | 0.52% | -1.15% | 0.71% |
| Net Income (Continuing) | -4.16M | -3.17M | -3.79M | -11.31M | -7.4M | -3.81M | -1.85M | -3.98M | -1.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -122.56 | -319.66 | -269.00 | -27.49 | -12.26 | -5.44 | -1.97 | -3.86 | -0.78 |
| EPS Growth % | - | -1.61% | 0.16% | 0.9% | 0.55% | 0.56% | 0.64% | -0.96% | 0.8% |
| EPS (Basic) | -122.56 | -319.66 | -269.00 | -27.49 | -12.26 | -5.44 | -1.97 | -3.86 | -0.78 |
| Diluted Shares Outstanding | 19.37K | 37.47K | 54.25K | 417.59K | 603.81K | 700.56K | 797.87K | 1.03M | 1.46M |
| Basic Shares Outstanding | 19.37K | 37.47K | 54.25K | 417.59K | 603.81K | 700.56K | 797.87K | 1.03M | 1.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 4.82M | 645.23K | 5.66M | 1.3M | 2.18M | 756.47K | 880.67K | 435.78K | 503.38K |
| Cash & Short-Term Investments | 4.68M | 348.2K | 30.01K | 487.95K | 376.43K | 71.08K | 249.46K | 91.44K | 106.65K |
| Cash Only | 4.68M | 348.2K | 30.01K | 487.95K | 376.43K | 71.08K | 249.46K | 91.44K | 106.65K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 8.45K | 347.49K | 32.18K | 799.25K | 722.16K | 464.85K | 336.03K | 304.81K | 372.72K |
| Days Sales Outstanding | 5.21 | 30.07 | 78.26 | 52.58 | 50.56 | 36.63 | 30.37 | 29.24 | 45.5 |
| Inventory | 0 | 0 | 5.4M | 0 | 998.44K | 156.6K | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | 676.44 | - | 103.67 | 20.54 | - | - | - |
| Other Current Assets | 0 | 254.89K | 5.6M | 0 | 0 | 0 | 295.18K | 39.53K | 24.01K |
| Total Non-Current Assets | 9.17M | 9.11M | 1.41M | 8.69M | 8.44M | 8.37M | 8.37M | 5.84M | 5.84M |
| Property, Plant & Equipment | 122.31K | 259.46K | 0 | 105.2K | 76.16K | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | 4.84x | 16.26x | - | 52.74x | 68.45x | - | - | - | - |
| Goodwill | 3.27M | 5.96M | 0 | 8.37M | 8.37M | 8.37M | 8.37M | 5.84M | 5.84M |
| Intangible Assets | 5.78M | 2.89M | 0 | 205.22K | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 1.41M | 17.56K | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 14M | 9.76M | 5.66M | 9.99M | 10.63M | 9.12M | 9.25M | 6.28M | 6.35M |
| Asset Turnover | 0.04x | 0.43x | 0.03x | 0.56x | 0.49x | 0.51x | 0.44x | 0.61x | 0.47x |
| Asset Growth % | - | -0.3% | -0.42% | 0.76% | 0.06% | -0.14% | 0.01% | -0.32% | 0.01% |
| Total Current Liabilities | 284.36K | 1.6M | 8.57M | 3.07M | 4.6M | 2.28M | 2.32M | 2.33M | 1.84M |
| Accounts Payable | 284.36K | 843.55K | 855.76K | 2M | 1.57M | 1.43M | 1.36M | 1.74M | 1.24M |
| Days Payables Outstanding | 269.99 | 114.4 | 107.18 | 166.54 | 163.03 | 187.94 | 189.72 | 250.21 | 201.34 |
| Short-Term Debt | 0 | 300K | 1.43M | 0 | 0 | 0 | 0 | 0 | 27.37K |
| Deferred Revenue (Current) | 0 | 56.74K | 816.71K | 0 | 1000K | 472.75K | 579.83K | 378.58K | 354.08K |
| Other Current Liabilities | 0 | 453.35K | 6.29M | 1.06M | 850K | 225K | 225K | 67.62K | 67.62K |
| Current Ratio | 16.96x | 0.40x | 0.66x | 0.42x | 0.47x | 0.33x | 0.38x | 0.19x | 0.27x |
| Quick Ratio | 16.96x | 0.40x | 0.03x | 0.42x | 0.26x | 0.26x | 0.38x | 0.19x | 0.27x |
| Cash Conversion Cycle | - | - | 647.52 | - | -8.8 | -130.77 | - | - | - |
| Total Non-Current Liabilities | 553.8K | 23.94K | 1.43M | 0 | 293.97K | 433.57K | 147.75K | 90.36K | 19.66K |
| Long-Term Debt | 553.8K | 0 | 1.59M | 0 | 293.97K | 433.57K | 147.75K | 90.36K | 19.66K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 23.94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -553.8K | 0 | -1.59M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 284.36K | 1.62M | 8.57M | 3.07M | 4.89M | 2.72M | 2.47M | 2.42M | 1.86M |
| Total Debt | 553.8K | 300K | 1.43M | 11.06K | 293.97K | 433.57K | 147.75K | 90.36K | 47.03K |
| Net Debt | -4.12M | -48.2K | 1.4M | -476.89K | -82.45K | 362.49K | -101.71K | -1.08K | -59.63K |
| Debt / Equity | 0.04x | 0.04x | - | 0.00x | 0.05x | 0.07x | 0.02x | 0.02x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -13.85x | -501.58x | - | - | -673.04x | -224.98x | -12.09x |
| Total Equity | 13.71M | 8.13M | -2.91M | 6.93M | 5.73M | 6.41M | 6.78M | 3.85M | 4.49M |
| Equity Growth % | - | -0.41% | -1.36% | 3.38% | -0.17% | 0.12% | 0.06% | -0.43% | 0.17% |
| Book Value per Share | 707.85 | 217.08 | -53.60 | 16.58 | 9.50 | 9.14 | 8.49 | 3.73 | 3.08 |
| Total Shareholders' Equity | 13.71M | 8.13M | -2.91M | 6.93M | 5.73M | 6.41M | 6.78M | 3.85M | 4.49M |
| Common Stock | 9.02K | 12.66K | 921 | 7.39K | 9.9K | 11.29K | 13.01K | 1.23K | 1.86K |
| Retained Earnings | -4.55M | -16.52M | -31.32M | -12.79M | -20.2M | -24.01M | -25.86M | -29.84M | -30.98M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | -5.5M | 0 | 0 | 0 | 600K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -2.02M | -5.57M | -3.58M | -4.69M | -959.07K | -1.07M | -540.04K | -806.16K | -1.08M |
| Operating CF Margin % | -3.41% | -1.32% | -23.84% | -0.85% | -0.18% | -0.23% | -0.13% | -0.21% | -0.36% |
| Operating CF Growth % | - | -1.76% | 0.36% | -0.31% | 0.8% | -0.12% | 0.5% | -0.49% | -0.35% |
| Net Income | -4.16M | -11.98M | -3.79M | -11.31M | -7.4M | -3.81M | -1.85M | -3.98M | -1.14M |
| Depreciation & Amortization | 397.44K | 830.12K | 40.83K | 41.23K | 234.26K | 76.16K | 0 | 0 | 0 |
| Stock-Based Compensation | 2.65M | 944K | 738.5K | 0 | 0 | 2.69M | 1.14M | 361.36K | 0 |
| Deferred Taxes | -755.65K | 680.44K | -770.48K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.48M | 3.33M | 186.2K | 7.71M | 4.97M | 530.76K | -44.47K | 2.57M | 193.64K |
| Working Capital Changes | -146.11K | 624.58K | 13.99K | -1.13M | 1.24M | -550.29K | 209.9K | 241.58K | -141.71K |
| Change in Receivables | 28.25K | -185.16K | -32.18K | -622.97K | 3.1K | 93.39K | 50.69K | -16.78K | -93.4K |
| Change in Inventory | 68.42M | 0 | -246.17K | 0 | -523.44K | 475K | 0 | 0 | 0 |
| Change in Payables | -68.61M | 746.14M | 246.17K | -719.17K | 848.47K | 0 | 0 | 0 | -39.33K |
| Cash from Investing | -1.85M | -1.07M | -21.85K | 4.92M | 0 | 0 | 0 | 165K | 0 |
| Capital Expenditures | -111.6K | -236.73K | 0 | -111.65K | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 0.19% | 0.06% | - | 0.02% | - | - | - | - | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -184.07K | -1.01M | -21.85K | -414.55K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 8.55M | 2.31M | 2.01M | 187.55K | 847.54K | 764.6K | 718.42K | 483.14K | 1.1M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | -278 | 0 | -200K | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | -6.48M | 0 | 515K | 100K | 0 | -32.38K | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -2.13M | -5.81M | -3.58M | -4.8M | -959.07K | -1.07M | -540.04K | -806.16K | -1.08M |
| FCF Margin % | -3.6% | -1.38% | -23.84% | -0.87% | -0.18% | -0.23% | -0.13% | -0.21% | -0.36% |
| FCF Growth % | - | -1.73% | 0.38% | -0.34% | 0.8% | -0.12% | 0.5% | -0.49% | -0.34% |
| FCF per Share | -109.95 | -154.97 | -65.97 | -11.50 | -1.59 | -1.53 | -0.68 | -0.78 | -0.74 |
| FCF Conversion (FCF/Net Income) | 0.49x | 0.47x | 0.25x | 0.41x | 0.13x | 0.28x | 0.29x | 0.20x | 0.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 131 | 6.45K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -30.33% | -109.66% | -558.36% | -571.43% | -116.94% | -62.85% | -28.03% | -74.9% | -27.24% |
| Return on Invested Capital (ROIC) | -38.42% | -95.68% | -81.72% | -361.31% | -74.94% | -46.07% | -23.7% | -20.67% | -22.81% |
| Gross Margin | 35% | 36.19% | -1841.73% | 21.02% | 32.57% | 39.94% | 35.01% | 33.35% | 24.95% |
| Net Margin | -703.27% | -284.01% | -9722.4% | -206.91% | -141.99% | -82.34% | -45.75% | -104.63% | -38.01% |
| Debt / Equity | 0.04x | 0.04x | - | 0.00x | 0.05x | 0.07x | 0.02x | 0.02x | 0.01x |
| Interest Coverage | - | - | -13.85x | -501.58x | - | - | -673.04x | -224.98x | -12.09x |
| FCF Conversion | 0.49x | 0.47x | 0.25x | 0.41x | 0.13x | 0.28x | 0.29x | 0.20x | 0.95x |
| Revenue Growth | - | 613.13% | -96.44% | 3596.55% | -6.04% | -11.14% | -12.83% | -5.78% | -21.43% |
| 2017 | |
|---|---|
| Promotion | 3.03M |
| Promotion Growth | - |
| Athlete Management | 934.04K |
| Athlete Management Growth | - |
| Ticket Service | 221.18K |
| Ticket Service Growth | - |
| Corporate | 36.33K |
| Corporate Growth | - |
SCWorx Corp. (WORX) reported $2.8M in revenue for fiscal year 2024. This represents a 371% increase from $0.6M in 2016.
SCWorx Corp. (WORX) saw revenue decline by 21.4% over the past year.
SCWorx Corp. (WORX) reported a net loss of $3.9M for fiscal year 2024.
SCWorx Corp. (WORX) has a return on equity (ROE) of -27.2%. Negative ROE indicates the company is unprofitable.
SCWorx Corp. (WORX) had negative free cash flow of $1.5M in fiscal year 2024, likely due to heavy capital investments.